We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Acorda Multiple Sclerosis Drug Patents Are Invalid, Federal Circuit Affirms

Mealey's (September 11, 2018, 2:23 PM EDT) -- WASHINGTON, D.C. — In a divided Sept. 10 holding, the Federal Circuit U.S. Court of Appeals upheld findings by a Delaware federal judge that four Acorda Therapeutics Inc. patents relating to...
To view the full article, register now.